Findings presented at the International VT Symposium and published simultaneously in Circulation. The FieldForce™ Ablation System by Field Medical: This next-generation PFA system is designed for ...
In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...
Limited information exists on whether ventricular tachycardia or fibrillation (VT/VF) affects the prognosis of patients undergoing percutaneous coronary intervention (PCI). After performing a ...
Presenting data last week at the American Heart Association 2006 Scientific Sessions, lead investigator Dr Christine Albert (Harvard Medical School, Boston, MA) and colleagues report that acute ...
January 29, 2004 — Are the doldrums of winter bringing you down? Apparently, they may be doing more than just affecting the psyche. Dirk Müller, MD, Free University (Berlin, Germany), and colleagues ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients with ventricular tachycardia indicated for an implantable cardioverter ...
The FieldForce™ Ablation System by Field Medical: This next-generation PFA system is designed for transmural lesion creation, offering a novel approach to VT ablation. "While this remains an initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback